吉姆·克雷默：
持有builders firstsource股票，viking therapeutics存在問題。
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
On CNBC's "Mad Money Lightning Round," Jim Cramer said Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is "great."
在CNBC的「狂熱金錢閃電回合」中，吉姆•克雷默說，福泰製藥公司（納斯達克：VRTX）非常好。
On Aug. 1, Vertex Pharmaceuticals reported second-quarter revenues of $2.65 billion, almost in line with the consensus of estimate of $2.66 billion. Vertex raised its 2024 product revenue guidance from $10.55 billion-$10.75 billion to $10.65 billion-$10.85 billion.
2021年8月1日，福泰製藥公司報告了第二季度收入26.5億美元，幾乎與26.6億美元的預估一致。福泰將2024年產品收入指導提升至106.5億美元至108.5億美元。
When asked about Serve Robotics Inc. (NASDAQ:SERV), he said, "We're not recommending companies that lose a ton of money because it's just not the right time."
當被問及Serve Robotics Inc.（納斯達克：SERV）時，他說：「我們不推薦那些大量虧損的公司，因爲這不是合適的時機。」
On Aug. 28, Serve Robotics announced closing of $20 million private placement & warrant exercise.
2021年8月28日，Serve Robotics宣佈完成了2000萬美元的定向增發和權證行權。
Builders FirstSource, Inc. (NYSE:BLDR) can "go higher," Cramer said, "This is precisely the kind of stock you should be buying at this stage in the cycle. Hold on."
Builders FirstSource, Inc.（紐交所：BLDR）可以「走得更高」，克雷默說，「這正是你應該在這個階段購買的股票。保持持有。」
On Aug. 6, Builders FirstSource reported second-quarter adjusted earnings per share of $3.50, beating the street view of $3.02. Quarterly sales of $4.456 billion missed the street view of $4.483 billion.
2021年8月6日，Builders FirstSource報告了每股調整後的第二季度收益達到3.50美元，超過了3.02美元的街頭預期。季度銷售額445.6億美元，低於448.3億美元的街頭預期。
"Here's the problem: it costs so much money to build the factories, they're going to have to get a takeover to be able to do that," Cramer said about Viking Therapeutics, Inc. (NASDAQ:VKTX).
「這是問題的所在：建設工廠需要花費很多錢，他們必須進行收購才能做到這一點，」克雷默談到Viking Therapeutics, Inc.（納斯達克：VKTX）時說。
On July 24, Viking Therapeutics reported better-than-expected second-quarter EPS results.
2021年7月24日，Viking Therapeutics報告了超出預期的第二季度每股收益結果。
Price Action:
價格行動：
- Serve Robotics shares fell 1.3% to settle at $9.35 on Wednesday.
- Builders FirstSource shares fell 1% to close at $172.90.
- Vertex Pharmaceuticals shares gained 2% to close at $489.73.
- Viking Therapeutics shares fell 0.4% to settle at $61.16 on Wednesday.
- Serve Robotics股票在週三下跌1.3%，收於9.35美元。
- Builders FirstSource股票在週三下跌1%，收於172.90美元。
- 福泰製藥股票在週三上漲2%，收於489.73美元。
- Viking Therapeutics股票在週三下跌0.4%，收於61.16美元。
- Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields
- 華爾街最準確的分析師聚焦於3家材料股，提供高股息回報。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。